NLSUI OPAC header image

Incentives for global public health (Record no. 40274)

MARC details
000 -LEADER
fixed length control field 02723nam a2200217Ia 4500
003 - CONTROL NUMBER IDENTIFIER
control field OSt
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20210217154017.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 160316s2010 xxu||||| |||| 00| 0 eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780521116565
040 ## - CATALOGING SOURCE
Transcribing agency n
082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 362.170000
Item number POG
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name Pogge Thomas
245 ## - TITLE STATEMENT
Title Incentives for global public health
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. Cambridge
Name of publisher, distributor, etc. Cambridge University Press
Date of publication, distribution, etc. 2010
300 ## - PHYSICAL DESCRIPTION
Extent 512p
Dimensions xix
365 ## - TRADE PRICE
Price amount Rs. 3,100
505 ## - FORMATTED CONTENTS NOTE
Formatted contents note Contents:<br/>Introduction: access to essential medicines: public health and international law Thomas Pogge, Matthew Rimmer and Kim Rubenstein;<br/>Part I. International Trade:<br/>1. TRIPS and essential medicines: must one size fit all? Making the WTO responsive to the global health crisis Rochelle Cooper Dreyfuss;<br/>2. The TRIPS waiver as a recognition of public health concerns in the WTO Andrew Mitchell and Tania Voon;<br/>3. Public law challenges to the regulation of pharmaceutical patents in the US Bilateral Free Trade Agreements Hitoshi Nasu;<br/>4. Global health and development: patents and public interest Elizabeth Siew Kuan Ng;<br/>Part II. Innovation:<br/>5. The Health Impact Fund: boosting innovation without obstructing free access Thomas Pogge;<br/>6. The Health Impact Fund: a critique Kathleen Liddell;<br/>7. A prize system as a partial solution to the health crisis in the developing world William W. Fisher and Talha Syed;<br/>8. Innovation and insufficient evidence: the case for a WTO-WHO agreement on health technology safety and cost-effectiveness evaluation Thomas Faunce;<br/>Part III. Intellectual Property:<br/>9. Opening the dam: patent pools, innovation, and access to essential medicines Dianne Nicol and Jane Nielsen;<br/>10. Open source drug discovery: a revolutionary paradigm or a utopian model? Krishna Ravi Srinivas;<br/>11. Accessing and benefit sharing avian influenza viruses through the World Health Organisation: a CBD and TRIPS compromise thanks to Indonesia's sovereignty claim? Charles Lawson and Barbara Hocking;<br/>12. The Lazarus effect: the (RED) campaign and creative capitalism Matthew Rimmer;<br/>Part IV. Health-Care:<br/>13. Beyond TRIPS: the role of non-state actors and access to essential medicines Noah Benjamin Novogrodsky;<br/>14. Securing health through rights Katharine Young;<br/>15. The role of national laws in reconciling constitutional right to health with TRIPS obligations: an examination of the Glivec patent case in India Rajshree Chandra;<br/>16. Tipping point: Thai compulsory licenses redefine essential medicines debate Jonathan Burton-MacLeod
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element 1. Drug - Organization & Administration - Legislation2. Drugs - Essential - Supply & Distribution3. Health Service Accessibility
700 ## - ADDED ENTRY--PERSONAL NAME
Personal name Rimer Mathew
-- Rubenstein Kim
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme Dewey Decimal Classification
Koha item type BOOKs
Holdings
Withdrawn status Lost status Damaged status Not for loan Home library Current library Shelving location Date acquired Cost, normal purchase price Total Checkouts Total Renewals Full call number Barcode Date last seen Date last checked out Price effective from Koha item type
        . .   30.05.2017 3100.97 1 1 362.17 POG 33967 26.10.2023 07.12.2022 30.05.2017 BOOKs